Sagimet Biosciences Inc
NASDAQ:SGMT

Watchlist Manager
Sagimet Biosciences Inc Logo
Sagimet Biosciences Inc
NASDAQ:SGMT
Watchlist
Price: 5.59 USD -7.14% Market Closed
Market Cap: 169.9m USD
Have any thoughts about
Sagimet Biosciences Inc?
Write Note

Sagimet Biosciences Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sagimet Biosciences Inc
Cash from Operating Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sagimet Biosciences Inc
NASDAQ:SGMT
Cash from Operating Activities
-$23.8m
CAGR 3-Years
-32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Operating Activities
$16.5B
CAGR 3-Years
-10%
CAGR 5-Years
4%
CAGR 10-Years
12%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Operating Activities
$10B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Cash from Operating Activities
$7.3B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Operating Activities
-$944m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-10%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Operating Activities
$4.2B
CAGR 3-Years
-11%
CAGR 5-Years
12%
CAGR 10-Years
18%

See Also

What is Sagimet Biosciences Inc's Cash from Operating Activities?
Cash from Operating Activities
-23.8m USD

Based on the financial report for Dec 31, 2023, Sagimet Biosciences Inc's Cash from Operating Activities amounts to -23.8m USD.

What is Sagimet Biosciences Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-32%

Over the last year, the Cash from Operating Activities growth was 3%. The average annual Cash from Operating Activities growth rates for Sagimet Biosciences Inc have been -32% over the past three years .

Back to Top